These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 24489509
1. Treatment of pseudomonas and Staphylococcus bronchopulmonary infection in patients with cystic fibrosis. Das RR, Kabra SK, Singh M. ScientificWorldJournal; 2013; 2013():645653. PubMed ID: 24489509 [Abstract] [Full Text] [Related]
4. Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis. Hansen C, Skov M. Ther Adv Respir Dis; 2015 Feb; 9(1):16-21. PubMed ID: 25471692 [Abstract] [Full Text] [Related]
9. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Banerjee D, Stableforth D. Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122 [Abstract] [Full Text] [Related]
10. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis. Ryan G, Jahnke N, Remmington T. Cochrane Database Syst Rev; 2012 Dec 12; 12():CD008319. PubMed ID: 23235659 [Abstract] [Full Text] [Related]
11. Oral anti-pseudomonal antibiotics for cystic fibrosis. Remmington T, Jahnke N, Harkensee C. Cochrane Database Syst Rev; 2016 Jul 14; 7(7):CD005405. PubMed ID: 27412131 [Abstract] [Full Text] [Related]
12. Oral anti-pseudomonal antibiotics for cystic fibrosis. Remmington T, Jahnke N, Harkensee C. Cochrane Database Syst Rev; 2013 Oct 29; (10):CD005405. PubMed ID: 24170644 [Abstract] [Full Text] [Related]
14. Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis. Moore JE, Mastoridis P. J Clin Pharm Ther; 2017 Jun 29; 42(3):259-267. PubMed ID: 28374433 [Abstract] [Full Text] [Related]
15. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB. Am J Respir Crit Care Med; 2008 Nov 01; 178(9):921-8. PubMed ID: 18658109 [Abstract] [Full Text] [Related]
16. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis. Langan KM, Kotsimbos T, Peleg AY. Curr Opin Infect Dis; 2015 Dec 01; 28(6):547-56. PubMed ID: 26524327 [Abstract] [Full Text] [Related]
17. Comparison of Inhaled Antibiotics for the Treatment of Chronic Pseudomonas aeruginosa Lung Infection in Patients With Cystic Fibrosis: Systematic Literature Review and Network Meta-analysis. Elborn JS, Vataire AL, Fukushima A, Aballea S, Khemiri A, Moore C, Medic G, Hemels ME. Clin Ther; 2016 Oct 01; 38(10):2204-2226. PubMed ID: 27692977 [Abstract] [Full Text] [Related]
18. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Smith S, Waters V, Jahnke N, Ratjen F. Cochrane Database Syst Rev; 2020 Jun 10; 6(6):CD009528. PubMed ID: 32520436 [Abstract] [Full Text] [Related]
19. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Langton Hewer SC, Smyth AR. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD004197. PubMed ID: 19821321 [Abstract] [Full Text] [Related]
20. The approach to Pseudomonas aeruginosa in cystic fibrosis. Bendiak GN, Ratjen F. Semin Respir Crit Care Med; 2009 Oct 07; 30(5):587-95. PubMed ID: 19760546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]